Terms: = Thyroid cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Prognosis
54 results:
1. Liver cancer stem cell dissemination and metastasis: uncovering the role of NRCAM in hepatocellular carcinoma.
Zhou L; He L; Liu CH; Qiu H; Zheng L; Sample KM; Wu Q; Li J; Xie K; Ampuero J; Li Z; Lv D; Liu M; Romero-Gómez M; Hu Y; Tang H
J Exp Clin Cancer Res; 2023 Nov; 42(1):311. PubMed ID: 37993901
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
[TBL] [Abstract] [Full Text] [Related]
3. Tetraspanin 1 regulates papillary thyroid tumor growth and metastasis through c-myc-mediated glycolysis.
Han J; Xie C; Liu B; Wang Y; Pang R; Bi W; Sheng R; He G; Kong L; Yu J; Ding Z; Chen L; Jia J; Zhang J; Nie C
Cancer Sci; 2023 Dec; 114(12):4535-4547. PubMed ID: 37750019
[TBL] [Abstract] [Full Text] [Related]
4. Methylation-Mediated Silencing of ATF3 Promotes thyroid cancer Progression by Regulating Prognostic Genes in the MAPK and PI3K/AKT Pathways.
Xiao X; Chen M; Sang Y; Xue J; Jiang K; Chen Y; Zhang L; Yu S; Lv W; Li Y; Liu R; Xiao H
Thyroid; 2023 Dec; 33(12):1441-1454. PubMed ID: 37742107
[No Abstract] [Full Text] [Related]
5. myc-Associated Zinc Finger Protein Promotes Metastasis of Papillary thyroid cancer.
Zheng C; Wu H; Zhang S; Tian R; Long H; Zhang H; Guo X; Li D; Tan S; Zhu X
Front Biosci (Landmark Ed); 2023 Aug; 28(8):162. PubMed ID: 37664917
[TBL] [Abstract] [Full Text] [Related]
6. Identification of BRAF, CCND1, and myc mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
[TBL] [Abstract] [Full Text] [Related]
7. mycBP2 expression correlated with inflammatory cell infiltration and prognosis immunotherapy in thyroid cancer patients.
Wang G; Miao C; Mo L; Kahlert UD; Wu J; Ou M; Huang R; Feng R; Pang W; Shi W
Front Immunol; 2022; 13():1048503. PubMed ID: 36582246
[TBL] [Abstract] [Full Text] [Related]
8. Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity.
Chen J; Li Z; Jia X; Song W; Wu H; Zhu H; Xuan Z; Du Y; Zhu X; Song G; Dong H; Bian S; Wang S; Zhao Y; Xie H; Zheng S; Song P
Oncogene; 2022 May; 41(22):3118-3130. PubMed ID: 35477750
[TBL] [Abstract] [Full Text] [Related]
9. Expression and clinical significance of BDH1 in liver cancer.
Liu Z; Li Y; Liu Y; Yang D; Jiao Y; Liu Y
Medicine (Baltimore); 2021 Dec; 100(48):e28013. PubMed ID: 35049211
[TBL] [Abstract] [Full Text] [Related]
10. INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma.
Zhou Q; Lin J; Yan Y; Meng S; Liao H; Chen R; He G; Zhu Y; He C; Mao K; Wang J; Zhang J; Zhou Z; Xiao Z
J Exp Clin Cancer Res; 2022 Jan; 41(1):13. PubMed ID: 34996491
[TBL] [Abstract] [Full Text] [Related]
11. CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502-5p/KRAS and IGF2BP2/myc axes.
Li J; Gao X; Zhang Z; Lai Y; Lin X; Lin B; Ma M; Liang X; Li X; Lv W; Lin Y; Zhang N
Mol Cancer; 2021 Oct; 20(1):138. PubMed ID: 34696797
[TBL] [Abstract] [Full Text] [Related]
12. Comprehensive analysis of aberrant alternative splicing related to carcinogenesis and prognosis of papillary thyroid cancer.
Zheng X; Feng L; Yin Y; Yu C; He X; Zhu J; Zhang M; Yu J; Xu M
Aging (Albany NY); 2021 Oct; 13(19):23149-23168. PubMed ID: 34628367
[TBL] [Abstract] [Full Text] [Related]
13. Second Malignancies after Radiation Therapy: Update on Pathogenesis and Cross-sectional Imaging Findings.
Khanna L; Prasad SR; Yedururi S; Parameswaran AM; Marcal LP; Sandrasegaran K; Tirumani SH; Menias CO; Katabathina VS
Radiographics; 2021; 41(3):876-894. PubMed ID: 33891523
[TBL] [Abstract] [Full Text] [Related]
14. In silico screening using bulk and single-cell RNA-seq data identifies RIMS2 as a prognostic marker in basal-like breast cancer: A retrospective study.
Zhang L; Liu Z; Zhu J
Medicine (Baltimore); 2021 Apr; 100(16):e25414. PubMed ID: 33879671
[TBL] [Abstract] [Full Text] [Related]
15. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
Pang R; Yang S
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
[TBL] [Abstract] [Full Text] [Related]
16. BGL3 inhibits papillary thyroid carcinoma progression via regulating PTEN stability.
Zhao M; Yang F; Sang C; Yan C; Wang Z
J Endocrinol Invest; 2021 Oct; 44(10):2165-2174. PubMed ID: 33543443
[TBL] [Abstract] [Full Text] [Related]
17. Pan-cancer Multiomics Analysis of TC2N Gene Suggests its Important Role(s) in Tumourigenesis of Many cancers.
Qureshi MA; Khan S; Tauheed MS; Syed SA; Ujjan ID; Lail A; Sharafat S
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3199-3209. PubMed ID: 33247676
[TBL] [Abstract] [Full Text] [Related]
18. TRIP13 promotes lung cancer cell growth and metastasis through AKT/mTORC1/c-myc signaling.
Cai W; Ni W; Jin Y; Li Y
Cancer Biomark; 2021; 30(2):237-248. PubMed ID: 33136091
[TBL] [Abstract] [Full Text] [Related]
19. A Multicenter Retrospective Study of 58 Patients With Primary thyroid Diffuse Large B Cell Lymphoma.
Yi J; Yi P; Wang W; Wang H; Wang X; Luo H; Fan P
Front Endocrinol (Lausanne); 2020; 11():542. PubMed ID: 32982962
[No Abstract] [Full Text] [Related]
20. Amino Acid Transporters as Potential Therapeutic Targets in thyroid cancer.
Enomoto K; Hotomi M
Endocrinol Metab (Seoul); 2020 Jun; 35(2):227-236. PubMed ID: 32615707
[TBL] [Abstract] [Full Text] [Related]
[Next]